- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Efficacy and Safety of Apatinib in Patients with Recurrent Glioblastoma ; volume:23 ; number:3 ; day:19 ; month:7 ; year:2023 ; pages:239-244 ; date:9.2023
Drugs in R & D ; 23, Heft 3 (19.7.2023), 239-244, 9.2023
- Urheber
-
Lin, Hao
Zhou, Xinli
Sheng, Xiaofang
Liang, Xiaohua
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40268-023-00429-3
- URN
-
urn:nbn:de:101:1-2023110414012246666285
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lin, Hao
- Zhou, Xinli
- Sheng, Xiaofang
- Liang, Xiaohua
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evaluation of the efficacy and safety of TAS0313 in adults with recurrent glioblastoma
The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial
Efficacy and safety of apatinib in patients with recurrent or metastatic head and neck squamous cell carcinoma: a retrospective multi-center study
Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression
BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety
Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma
Recurrent glioblastoma: Nuances and insights
Recurrent Glioblastoma: Where we stand
Efficacy and safety of apatinib combined with radiotherapy in the treatment of advanced pancreatic cancer: a meta-analysis
Efficacy and safety of apatinib in the treatment of osteosarcoma: a single-arm meta-analysis among Chinese patients
Evaluation of the efficacy and safety of TAS0313 in adults with recurrent glioblastoma
The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial
Efficacy and safety of apatinib in patients with recurrent or metastatic head and neck squamous cell carcinoma: a retrospective multi-center study
Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression
BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety
Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma
Recurrent glioblastoma: Nuances and insights
Recurrent Glioblastoma: Where we stand
Efficacy and safety of apatinib combined with radiotherapy in the treatment of advanced pancreatic cancer: a meta-analysis
Efficacy and safety of apatinib in the treatment of osteosarcoma: a single-arm meta-analysis among Chinese patients
Evaluation of the efficacy and safety of TAS0313 in adults with recurrent glioblastoma
The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial
Efficacy and safety of apatinib in patients with recurrent or metastatic head and neck squamous cell carcinoma: a retrospective multi-center study
Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression
BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety
Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma
Recurrent glioblastoma: Nuances and insights
Recurrent Glioblastoma: Where we stand
Efficacy and safety of apatinib combined with radiotherapy in the treatment of advanced pancreatic cancer: a meta-analysis